Roche increase gene therapy footprint with $1.5 billion licensing deal with Sarepta Therapeutics

On Monday, in a statement Roche said, it has entered into a $1.15 billion licensing deal with Sarepta Therapeutics to obtain the right to launch and commercialize Sarepta’s investigational gene therapy for Duchenne muscular dystrophy (DMD) outside the United States. Roche will be making an upfront payment of $750 million in cash and $400 million…

U.S. Security Agencies have proof of Russians influencing U.S. Presidential elections 2016

A leaked “Top Secret Signals Intelligence” classified report could make or break Trump’s presidency. Although the CIA, FBI and U.S. President Barrack Obama are all on the same page which clearly states that Russia hacked the DNC and influenced the results of the US. Presidential elections of 2016, President-elect Donald Trump who has emerged as…